Synopsis
Synopsis
0
JDMF
0
VMF
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cefuroxime
2. Cephuroxime
3. Ketocef
4. Zinacef
1. Sodium Cefuroxime
2. Zinacef
3. Cefuroxime Sodium Salt
4. Biociclin
5. 56238-63-2
6. Anaptivan
7. Kefurox
8. Cefuroxime (sodium)
9. Cefumax
10. Cefurex
11. Medoxim
12. Kesint
13. Chebi:3517
14. R8a7m9my61
15. Colifossim
16. Sodium (6r,7r)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(z)-(o-methyloxime), Carbamate (ester)
17. Spectrazolr
18. Bioxima
19. Cefofix
20. Curoxim
21. Curoxima
22. Curoxime
23. Furoxil
24. Ketocef
25. Ultroxim
26. Cefuroxim Hexal
27. Cefuroxim Lilly
28. Cefuroxima Fabra
29. Cefuroxim Aj
30. Cefuroxim Mn
31. Cefuroxim Curasan
32. Cefuroxima Richet
33. Cetroxil [inj.]
34. Cefuroxim Fresenius
35. Cefuroxim Genericsn
36. Froxal [inj.]
37. Sharox [inj.]
38. Zinnat [inj.]
39. Cetroxil
40. Froxal
41. Cefuroxim Norcox
42. Cefuroxim Norcox [inj.]
43. Cefuroxime Na
44. Kefurox In Plastic Container
45. Zinacef In Plastic Container
46. Zinacef (tn)
47. Einecs 260-073-1
48. Cefuroxime And Dextrose In Duplex Container
49. Unii-r8a7m9my61
50. Mls000069576
51. Cefuroxime Sodium [usp:ban:jan]
52. Cefuroxime For Injection And Dextrose For Injection In Duplex Container
53. Sodium;(6r,7r)-3-(carbamoyloxymethyl)-7-[[(2z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
54. Ks-1040
55. Smr000058808
56. Mls001332625
57. Mls001332626
58. Sodium (6r-(6alpha,7beta(z)))-3-(((aminocarbonyl)oxy)methyl)-7-(2-furyl(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
59. Cefuroxime Sodium (jan/usp)
60. Schembl719536
61. Cefuroxime Sodium [jan]
62. Chembl2146124
63. Cefuroxime Sodium [vandf]
64. Cefuroxime Sodium [mart.]
65. Dtxsid201015616
66. Hms2097o21
67. Hms3714o21
68. Cefuroxime Sodium [usp-rs]
69. Cefuroxime Sodium [who-dd]
70. Cefuroxime Sodium Salt [mi]
71. Hy-b1256
72. Mfcd09878727
73. S4620
74. Akos015961772
75. Ccg-220720
76. Cefuroxime Sodium [ep Impurity]
77. Cefuroxime Sodium [orange Book]
78. Cs-4733
79. Nsc 758166
80. Cefuroxime Sodium [ep Monograph]
81. Cefuroxime Sodium [usp Impurity]
82. Cefuroxime Sodium [usp Monograph]
83. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, Monosodium Salt (6r-(6alpha,7beta(z)))-
84. Ac-15028
85. C08108
86. D00915
87. Cefuroxime Sodium 100 Microg/ml In Acetonitrile/water
88. Cefuroxime Sodium 100 Microg/ml In Acetonitrile:water
89. Cefuroxime Sodium, European Pharmacopoeia (ep) Reference Standard
90. Cefuroxime Sodium, United States Pharmacopeia (usp) Reference Standard
91. (6r,7r)-3-(carbamoyloxymethyl)-7-[[(2z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
92. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, Monosodium Salt (6r-(6.alpha.,7.beta.(z)))-
93. Sodium (6r,7r)-3-(carbamoyloxymethyl)-7-((e)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Molecular Weight | 446.4 g/mol |
---|---|
Molecular Formula | C16H15N4NaO8S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 8 |
Exact Mass | 446.05082891 g/mol |
Monoisotopic Mass | 446.05082891 g/mol |
Topological Polar Surface Area | 202 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 804 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Cefuroxime and dextrose in duplex container |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 750mg base/vial; eq 1.5gm base/vial |
Market Status | Prescription |
Company | B Braun |
2 of 6 | |
---|---|
Drug Name | Cefuroxime sodium |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Intramuscular, intravenous; Im-iv; Injection |
Strength | eq 750mg base/vial; eq 7.5gm base/vial; eq 1.5gm base/vial |
Market Status | Prescription |
Company | Teva Pharms; Hospira; Steri Pharma; Hikma Farmaceutica |
3 of 6 | |
---|---|
Drug Name | Zinacef in plastic container |
Drug Label | Cefuroxime is a sterile semisynthetic, broad-spectrum, cephalosporin antibiotic for parenteral administration. It is the sodium salt of (6R, 7R)-3-carbamoyloxymethyl-7-[Z-2-methoxyimino-2-(fur-2-yl)acetamido]ceph-3-em-4-carboxylate, and it has the fo... |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 30mg base/ml |
Market Status | Prescription |
Company | Covis Injectables |
4 of 6 | |
---|---|
Drug Name | Cefuroxime and dextrose in duplex container |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 750mg base/vial; eq 1.5gm base/vial |
Market Status | Prescription |
Company | B Braun |
5 of 6 | |
---|---|
Drug Name | Cefuroxime sodium |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Intramuscular, intravenous; Im-iv; Injection |
Strength | eq 750mg base/vial; eq 7.5gm base/vial; eq 1.5gm base/vial |
Market Status | Prescription |
Company | Teva Pharms; Hospira; Steri Pharma; Hikma Farmaceutica |
6 of 6 | |
---|---|
Drug Name | Zinacef in plastic container |
Drug Label | Cefuroxime is a sterile semisynthetic, broad-spectrum, cephalosporin antibiotic for parenteral administration. It is the sodium salt of (6R, 7R)-3-carbamoyloxymethyl-7-[Z-2-methoxyimino-2-(fur-2-yl)acetamido]ceph-3-em-4-carboxylate, and it has the fo... |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 30mg base/ml |
Market Status | Prescription |
Company | Covis Injectables |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
61
PharmaCompass offers a list of Cefuroxime Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefuroxime Sodium manufacturer or Cefuroxime Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefuroxime Sodium manufacturer or Cefuroxime Sodium supplier.
PharmaCompass also assists you with knowing the Cefuroxime Sodium API Price utilized in the formulation of products. Cefuroxime Sodium API Price is not always fixed or binding as the Cefuroxime Sodium Price is obtained through a variety of data sources. The Cefuroxime Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cefuroxime sodium salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefuroxime sodium salt, including repackagers and relabelers. The FDA regulates Cefuroxime sodium salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefuroxime sodium salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cefuroxime sodium salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cefuroxime sodium salt supplier is an individual or a company that provides Cefuroxime sodium salt active pharmaceutical ingredient (API) or Cefuroxime sodium salt finished formulations upon request. The Cefuroxime sodium salt suppliers may include Cefuroxime sodium salt API manufacturers, exporters, distributors and traders.
click here to find a list of Cefuroxime sodium salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cefuroxime sodium salt DMF (Drug Master File) is a document detailing the whole manufacturing process of Cefuroxime sodium salt active pharmaceutical ingredient (API) in detail. Different forms of Cefuroxime sodium salt DMFs exist exist since differing nations have different regulations, such as Cefuroxime sodium salt USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cefuroxime sodium salt DMF submitted to regulatory agencies in the US is known as a USDMF. Cefuroxime sodium salt USDMF includes data on Cefuroxime sodium salt's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cefuroxime sodium salt USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cefuroxime sodium salt suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefuroxime sodium salt Drug Master File in Korea (Cefuroxime sodium salt KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefuroxime sodium salt. The MFDS reviews the Cefuroxime sodium salt KDMF as part of the drug registration process and uses the information provided in the Cefuroxime sodium salt KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefuroxime sodium salt KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefuroxime sodium salt API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefuroxime sodium salt suppliers with KDMF on PharmaCompass.
A Cefuroxime sodium salt CEP of the European Pharmacopoeia monograph is often referred to as a Cefuroxime sodium salt Certificate of Suitability (COS). The purpose of a Cefuroxime sodium salt CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cefuroxime sodium salt EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cefuroxime sodium salt to their clients by showing that a Cefuroxime sodium salt CEP has been issued for it. The manufacturer submits a Cefuroxime sodium salt CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cefuroxime sodium salt CEP holder for the record. Additionally, the data presented in the Cefuroxime sodium salt CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cefuroxime sodium salt DMF.
A Cefuroxime sodium salt CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cefuroxime sodium salt CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cefuroxime sodium salt suppliers with CEP (COS) on PharmaCompass.
A Cefuroxime sodium salt written confirmation (Cefuroxime sodium salt WC) is an official document issued by a regulatory agency to a Cefuroxime sodium salt manufacturer, verifying that the manufacturing facility of a Cefuroxime sodium salt active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cefuroxime sodium salt APIs or Cefuroxime sodium salt finished pharmaceutical products to another nation, regulatory agencies frequently require a Cefuroxime sodium salt WC (written confirmation) as part of the regulatory process.
click here to find a list of Cefuroxime sodium salt suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cefuroxime sodium salt as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cefuroxime sodium salt API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cefuroxime sodium salt as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cefuroxime sodium salt and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cefuroxime sodium salt NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cefuroxime sodium salt suppliers with NDC on PharmaCompass.
Cefuroxime sodium salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefuroxime sodium salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefuroxime sodium salt GMP manufacturer or Cefuroxime sodium salt GMP API supplier for your needs.
A Cefuroxime sodium salt CoA (Certificate of Analysis) is a formal document that attests to Cefuroxime sodium salt's compliance with Cefuroxime sodium salt specifications and serves as a tool for batch-level quality control.
Cefuroxime sodium salt CoA mostly includes findings from lab analyses of a specific batch. For each Cefuroxime sodium salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefuroxime sodium salt may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefuroxime sodium salt EP), Cefuroxime sodium salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefuroxime sodium salt USP).